Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

The pharmacologic treatment of anxiety disorders: a review of progress

LN Ravindran, MB Stein - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised …

G Andrews, C Bell, P Boyce, C Gale… - Australian & New …, 2018 - journals.sagepub.com
Objective: To provide practical clinical guidance for the treatment of adults with panic
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008 - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis

D Baldwin, R Woods, R Lawson, D Taylor - Bmj, 2011 - bmj.com
Objective To appraise the evidence for comparative efficacy and tolerability of drug
treatments in patients with generalised anxiety disorder. Design Systematic review of …

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

A Palucha, A Pilc - Pharmacology & therapeutics, 2007 - Elsevier
Depression and anxiety represent a major problem. However, the current treatment of both
groups of diseases is not satisfactory. As the glutamatergic system may play an important …

Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic-and antidepressant-like behaviors

CS Kim, PY Chang, D Johnston - Neuron, 2012 - cell.com
The hippocampus is an integral brain region for affective disorders. TRIP8b knockout mice
lacking functional HCN channels as well as both HCN1 and HCN2 knockout mice have …

Anxiety disorders: a comprehensive review of pharmacotherapies

EJ Hoffman, SJ Mathew - Mount Sinai Journal of Medicine: A …, 2008 - Wiley Online Library
This article reviews the evidence from randomized, placebo‐controlled trials and meta‐
analyses of pharmacological treatments of the following anxiety disorders: generalized …

Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine

J Liu, JC Garza, J Bronner, CS Kim, W Zhang… - Psychopharmacology, 2010 - Springer
Rationale Our previous studies in rats have shown that the adipocyte-derived hormone
leptin induces antidepressant-like effects with a behavioral profile similar to selective …

Тревожные и депрессивные расстройства: коморбидность и терапия

СН Мосолов - Биологические методы терапии психических …, 2012 - elibrary.ru
Работа посвящена актуальной проблеме часто встречающихся в клинической практике
больных с сочетанием тревожной и депрессивной симптоматики. Рассматриваются …